- Source type
- Study
- Access type
- Abstract/index
- Publisher
- PubMed
- Indexed by
- PubMed
- Date
- 2024
- Added
- 2026-06-19
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
91
Government health research
- Publisher type
- Government research
- Bias profile
- Low
This source is strongest for safety and clinical outcomes and weaker for consumer context and regulatory status.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 66/100
- Context Source
- Clinical outcomes
- 90/100
- Primary Anchor
- Mechanism
- 90/100
- Primary Anchor
- Safety
- 92/100
- Primary Anchor
- Consumer context
- 88/100
- Strong Support
- Trial discovery
- 89/100
- Strong Support
Best used for
- Research synthesis
- Public-health context
- Safety resources
Weak for
- Primary endpoint extraction when a study is available
Used in Viral Vitalism
GLP-1s Are Not Just a Weight Loss Story
Roles: Primary source
Show section-level references
Tirzepatide for the treatment of obstructive sleep apnea and obesity
Roles: Primary source
Show section-level references
Claim ledger
Claims supported
Reviewed claim cards that cite this source in the evidence graph.
Related studies
Related sources
FDA approves Zepbound as first medication for obstructive sleep apnea in adults with obesity
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 6 connections
Tirzepatide for the treatment of obstructive sleep apnea and obesity
New England Journal of Medicine used across the Viral Vitalism evidence library.
- Trust score
- 88
- Publisher
- New England Journal of Medicine
- Access
- Publisher
- Usage
- 4 connections
SURMOUNT-MMO trial registry: tirzepatide and morbidity/mortality in obesity
ClinicalTrials.gov / Lilly Trial Registry used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov / Lilly Trial Registry
- Access
- Publisher
- Usage
- 3 connections
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections